首頁 > 市場調查報告書 > 醫療設備

靜脈曲張治療市場規模、佔有率和成長分析（按類型、產品、應用和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898305

靜脈曲張治療市場規模、佔有率和成長分析（按類型、產品、應用和地區分類）—產業預測（2026-2033 年）

Varicose Veins Treatment Market Size, Share, and Growth Analysis, By Type (Endovenous Ablation, Injection Sclerotherapy), By Products (Ablation Devices, Radiofrequency Ablation Devices), By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球靜脈曲張治療市場預計到 2024 年將達到 13.9 億美元，到 2025 年將達到 14.8 億美元，到 2033 年將達到 24.9 億美元，預測期（2026-2033 年）的複合年成長率為 6.7%。

全球靜脈曲張治療市場正經歷強勁成長，這主要受人口老化和久坐生活方式等因素導致疾病盛行率不斷上升的推動。人們對有效治療方法的需求日益成長，尤其是微創手術，例如雷射消熔、硬化療法和射頻消融，這些療法與傳統手術相比具有疼痛更輕、恢復更快、疤痕更少等優勢。超音波泡沫硬化療法和非熱消融等技術進步提高了治療效果，改善了患者的治療結果和滿意度。然而，保險覆蓋範圍、高成本以及某些地區認知度不足等挑戰可能會阻礙市場准入。現有企業和新參與企業之間的激烈競爭需要持續的研發投入，而監管障礙可能會延遲新產品的上市，並影響市場趨勢。

全球靜脈曲張治療市場成長要素

全球靜脈曲張治療市場的成長歸功於人們對靜脈曲張及其各種治療方案的認知和了解不斷提高。公共教育活動、病患教育宣傳活動以及跨平台的資訊共用，都促使靜脈曲張患者尋求合適的治療方案。這種認知的提升不僅增強了個人自主管理健康的主導，也提高了他們尋求醫療介入的意願，從而推動了市場需求。預計更廣泛的認知將進一步促進該行業的擴張。

阻礙因素

全球靜脈曲張治療市場面臨許多挑戰，主要源自於法規要求和產品核可流程的複雜性。製造商在獲得必要的核准過程中往往耗時且耗力，這阻礙了新治療方法和創新技術的及時上市。此外，應對多個國家不同的監管規定也帶來了更多挑戰，這些障礙不僅影響市場成長，也限制了患者獲得先進治療方案的機會。因此，這些監管障礙可能會減緩有效靜脈曲張治療方法的整體研發和市場推廣。

全球靜脈曲張治療市場趨勢

全球靜脈曲張治療市場正呈現顯著的多模式治療趨勢，協同結合多種治療治療方法，以提升患者療效。整合諸如腔內消融術和硬化療法等技術，使醫療服務提供者能夠有效應對靜脈疾病的多個方面，從而提高整體治療效果並提升患者滿意度。這種對綜合辦法日益成長的偏好，不僅最大限度地提高了治療效果，也滿足了人們對微創高效解決方案日益成長的需求，從而塑造了全球靜脈曲張治療的未來格局。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2023 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2023）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Medtronic plc（Ireland）
AngioDynamics, Inc.（USA）
Teleflex Incorporated（USA）
Boston Scientific Corporation（USA）
Lumenis Ltd.（Israel）
Quanta System SpA（Italy）
Biolitec AG（Austria）
Dornier MedTech GmbH（Germany）
Sciton, Inc.（USA）
Fotona doo（Slovenia）
Viatris Inc.（USA）
Merz Aesthetics（USA）
SIGVARIS Group（Switzerland）
Essity Aktiebolag（publ）（Sweden）
F Care Systems NV（Belgium）
VVT Medical（Israel）
Alma Lasers（Israel）
Energist Group（UK）.
Eufoton srl（Italy）
WONTECH Co., Ltd.（South Korea）

結論與建議

簡介目錄

Product Code: SQMIG35E2025

Global Varicose Veins Treatment Market size was valued at USD 1.39 Billion in 2024 and is poised to grow from USD 1.48 Billion in 2025 to USD 2.49 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global varicose veins treatment market is witnessing robust growth, driven by the increasing prevalence of this condition due to factors like aging populations and sedentary lifestyles. The demand for effective treatments is on the rise, particularly for minimally invasive procedures such as laser ablation, sclerotherapy, and radiofrequency ablation, which offer advantages like lower pain, quicker recovery, and less scarring compared to traditional surgeries. Technological advancements, including ultrasound-guided foam sclerotherapy and non-thermal ablation, have enhanced treatment efficacy, improving patient outcomes and satisfaction. However, challenges such as reimbursement issues, high costs, and limited awareness in some regions can hinder market accessibility. Intense competition among existing and new players necessitates ongoing research and development, while regulatory hurdles may delay new product launches, impacting market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Varicose Veins Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Varicose Veins Treatment Market Segments Analysis

Global Varicose Veins Treatment Market is segmented by type, products, end use and region. Based on type, the market is segmented into endovenous ablation, injection sclerotherapy and surgical ligation & stripping. Based on products, the market is segmented into ablation devices, radiofrequency ablation devices, laser ablation devices and venous closure products. Based on end use, the market is segmented into hospitals, ambulatory surgical centers and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Varicose Veins Treatment Market

The growth of the Global Varicose Veins Treatment market can be attributed to heightened awareness and education about varicose veins and the various treatment alternatives available. Initiatives aimed at increasing public knowledge, alongside patient education campaigns and information sharing across multiple platforms, have motivated those suffering from varicose veins to pursue suitable treatment options. This surge in understanding has not only empowered individuals to take charge of their health but has also enhanced their willingness to seek medical intervention, thereby driving demand within the market. As awareness continues to spread, it is expected to further support the industry's expansion.

Restraints in the Global Varicose Veins Treatment Market

The global varicose veins treatment market faces significant challenges due to regulatory requirements and the complexities of product approval processes. Manufacturers often encounter prolonged and costly procedures when seeking necessary approvals, which can hinder the timely introduction of novel treatments and innovations. Compliance with diverse regulations across multiple countries adds another layer of difficulty, creating obstacles that can impact market growth and limit the availability of advanced therapeutic options for patients. Consequently, these regulatory hurdles can slow down the overall development and expansion of effective varicose veins treatments in the marketplace.

Market Trends of the Global Varicose Veins Treatment Market

The Global Varicose Veins Treatment market is witnessing a significant trend towards combination therapies, where various treatment modalities are used synergistically to enhance patient outcomes. By integrating techniques like endovenous ablation and sclerotherapy, healthcare providers can effectively address multiple facets of venous disease, improving the overall efficacy of treatments while simultaneously boosting patient satisfaction. This growing preference for comprehensive approaches not only maximizes therapeutic results but also caters to the increasing demand for minimally invasive and efficient solutions, thereby shaping the future landscape of varicose vein management globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Varicose Veins Treatment Market Size by Type & CAGR (2025-2031)

Market Overview
Endovenous Ablation
- Endovenous Laser Therapy
- Radiofrequency Ablation
Injection Sclerotherapy
Surgical Ligation & Stripping

Global Varicose Veins Treatment Market Size by Products & CAGR (2025-2031)

Market Overview
Ablation Devices
Radiofrequency Ablation Devices
Laser Ablation Devices
Venous Closure Products

Global Varicose Veins Treatment Market Size by End Use & CAGR (2025-2031)

Market Overview
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Global Varicose Veins Treatment Market Size & CAGR (2025-2031)

North America (Type, Products, End Use)
- US
- Canada
Europe (Type, Products, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Products, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Products, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Products, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lumenis Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quanta System S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biolitec AG (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dornier MedTech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciton, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fotona d.o.o. (Slovenia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viatris Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merz Aesthetics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SIGVARIS Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Essity Aktiebolag (publ) (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F Care Systems NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VVT Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alma Lasers (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Energist Group (UK).
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eufoton s.r.l. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WONTECH Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments